Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05537064 · ClinicalTrials.gov registry record · NA

Centralized Prescribing for Statins

A NA study of Hyperlipidemias, sponsored by University of Pennsylvania.

Active
Registry status
NA
Development phase
1,950
Enrollment target
1
Study location

NCT05537064 is a NA study of Hyperlipidemias that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 1,950 participants, below the 3,928-participant average among 21 other Hyperlipidemias trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05537064, a NA study of Hyperlipidemias, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,950 participants
Enrollment target
1
Study location

Study Summary

This pilot study consists of a pair of pragmatic clinical trials that will evaluate two separate methods for optimizing referral of eligible patients to a centralized pharmacy service for statin management: 1) A stepped wedge clinical trial, with randomization at the level of the provider, evaluating a visit-based nudge for referral to pharmacy services versus usual care; 2) A cluster randomized trial, with randomization at the level of the practice, evaluating a non-visit based nudge for referral to pharmacy services versus usual care.

Conditions Studied

Interventions

  • BEHAVIORAL Non-visit Based Intervention
  • BEHAVIORAL Visit-Based Intervention

Study Locations (1)

Pennsylvania

  • Lancaster General Hospital - Lancaster

Trial Details

FieldValue
Enrollment Target 1,950 participants
Start Date 2022-11-02
Est. Completion 2026-02
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT05537064

The ClinicalTrials.gov registry entry for NCT05537064 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,950 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,928-participant average among 21 other Hyperlipidemias trials with a reported enrollment target (50% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hyperlipidemias appearing as the primary indexed condition, and to 2 interventions - of which Non-visit Based Intervention is the first listed.

NCT05537064 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05537064 about?

NCT05537064 is a clinical study titled "Centralized Prescribing for Statins". This pilot study consists of a pair of pragmatic clinical trials that will evaluate two separate methods for optimizing referral of eligible patients to a centralized pharmacy service for statin management: 1) A stepped wedge clinical trial, with randomization at the level of the provider, evaluatin...

What is the current status of trial NCT05537064?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,950 participants. The study started on 2022-11-02. Estimated completion is 2026-02.

What conditions does trial NCT05537064 study?

This clinical trial studies the following conditions: Hyperlipidemias.

What interventions are being tested in trial NCT05537064?

The interventions under investigation include: Non-visit Based Intervention (BEHAVIORAL), Visit-Based Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05537064?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05537064 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hyperlipidemias

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.